Simu Thomas

Simu Thomas is a distinguished Market Access and Health Economics & Outcomes Research Executive with a rich background spanning over 20 years in both global and country leadership roles within the pharmaceutical industry.

With an impressive academic foundation that includes a PhD in Pharmaceutical Economics from the University of Maryland Baltimore, an MS in Pharmaceutical Economics from The University of Toledo, and an M Pharm and BPharm (Hons) from Birla Institute of Technology and Science, Simu Thomas possesses a strong educational background to complement his professional experience.

Throughout his career, Simu Thomas has held key positions in renowned organizations such as Alexion Pharmaceuticals, AstraZeneca Rare Disease where he served as Vice President & Global Head, Health Economics & Outcomes Research, contributing significantly to the company's success.

In addition to his industry roles, Simu Thomas has dedicated his expertise to academia, serving as an Adjunct Associate Professor at Rutgers University and an Adjunct Assistant Professor at the University of Maryland, further showcasing his commitment to sharing knowledge and shaping future pharmaceutical leaders.

Simu Thomas' extensive experience includes leadership roles at Novartis, where he held various global responsibilities such as Global Head, Value & Access - Rare Diseases, Global Head, Market Access & HEOR for Cell and Gene Therapies Unit, and Executive Director roles in Health Economics & Outcomes Research.

Simu Thomas has also contributed to the industry in his early career stages with roles like Product Manager, Marketing at Eros Pharmaceuticals and Research Assistant/consultant at the University of Maryland Center on Drugs and Public Policy, illustrating his well-rounded expertise within the pharmaceutical sector.

Currently serving as a Board Member at the Alexion Charitable Foundation, Simu Thomas continues to shape the industry landscape with his profound knowledge and leadership skills, offering valuable insights into Market Access and Health Economics & Outcomes Research.